RDDT Values

It is All About the Patient!

Patients First, Customers Second, Us third

Patients First, Customers Second, Us third

Patients First, Customers Second, Us third

Patients First, Customers Second, Us third

Patients First, Customers Second, Us third

Accountable for your Results, Really!

Patients First, Customers Second, Us third

Integrity: Do what’s right, legally and morally

Integrity: Do what’s right, legally and morally

Rare Disease & the Diagnostic Odyssey are the Enemy

Integrity: Do what’s right, legally and morally

Compliance makes it all possible

Rare Disease & the Diagnostic Odyssey are the Enemy

Rare Disease & the Diagnostic Odyssey are the Enemy

Rare Disease & the Diagnostic Odyssey are the Enemy

Rare Disease & the Diagnostic Odyssey are the Enemy

Rare Disease & the Diagnostic Odyssey are the Enemy

Executive Team

CEO Co-Founder

Chief Technology Officer

CEO Co-Founder

image10

David S. Connor

  • Co-Founder RDDT
  • 30 years in the pharmaceutical industry in sales & marketing
  • 20 years in the rare and ultra rare disease marketplace
  • 7 First to market, first in therapy rare and ultra rare disease product launches
  • 8 Biotech Commercial Start ups in Rare & Ultra Rare Disease
  • Schering-Plough, Rhone Poulenc Rorer, Merck, Guilford, Pharmion, Viropharma, Shire Human Genetics, Aegerion, MTPA
  • BS, Business Marketing, Florida State University 

COO Co-Founder

Chief Technology Officer

CEO Co-Founder

Kerry Hart

  • Co-Founder RDDT
  • 30 years healthcare corporate leader and entrepreneur
  • CEO of healthcare interim management and operations improvement company
  • CEO of $300MM national case management and physician peer review company
  • National practice leader for Arthur Andersen Business Consulting
  • Led Aetna’s Southeast region managed care operations
  • MA, Organizational Behavior, Western Kentucky University
  • BS, Agribusiness & Journalism, Western Kentucky University

Chief Technology Officer

Chief Technology Officer

Chief Financial Officer Fractional

 Matthew J. Erickson

  • 20+ Years in the Healthcare and Pharmaceutical Industry
  • 20+ years of successfully achieving business results through large and small teams of IT professionals across many levels, geographies, and technologies 
  • Focused skill set in Software Development focusing on delivering quality, on- time IT solutions that are stable, supportable, and scalable
  • BS, Computer Science, The Ohio State University

Chief Financial Officer Fractional

Chief Financial Officer Fractional

Chief Financial Officer Fractional

image11

Chris Dooney, CPA

  • 10+ years of healthcare and life sciences experience in the areas of advisory/consulting, financial services, and operating companies, including by not limited to, knowledge in healthcare providers & services (acute, behavioral, & post-acute), biotech & pharma, medical technology (MedTech), managed care (Payors), healthcare IT (HCIT) , and consumer-driven healthcare.


Chief Security & Safety Consultant

Chief Financial Officer Fractional

Chief Security & Safety Consultant

image12

Skeet Spillane 

Pillar Technologies Partners

  • Mr. Spillane has 25+ years of experience in Information Security. Specific areas of expertise Cyber Security Strategy, Information Security Operations, Threat Intelligence and Analysis, Vulnerability Analysis, Incident Response, Emergency Preparedness, Cyber Forensic Analysis, Regulatory Compliance (HIPAA/HITRUST, GDPR, ISO27001/2, PCI) and Security Architecture, Business Process Improvement, Cryptography / Cryptanalysis
  • He is a Certified Information Systems Security Professional, (CISSP), a Certified HIPAA Security Professional, (CHSP) and A Six Sigma Master Black Belt

Chief Data Scientist

Chief Financial Officer Fractional

Chief Security & Safety Consultant

image13

Support Team

CRO Co-Founder

Chief Medical Officer

Chief Medical Officer

image14

Brock Weathers

  • Co-Founder RDDT
  • 30 years Sales and Marketing experience in medical & pharmaceutical, ranging from medical devices to Bio-pharma Start-up 
  • 20 years devoted to Rare Disease in Hematology and Oncology with 8 product launches.  
  • 9 years in Ultra Rare Disease with 2 product launches in HAE & Fabry Disease 
  • Bachelor of Science in Marketing, University of Alabama

Chief Medical Officer

Chief Medical Officer

Chief Medical Officer

image15

ETL Data Specialist

Chief Medical Officer

Chief Compliance Officer

image16

Randal Green

  • Over 15 years experience in healthcare data analytics
  • Data extraction and analytics for over 80 hospitals ranging from CAH to 600+ beds as well as over 300 physicians and ambulatory surgery centers
  • Created readmission prediction algorithm that ranks #1 in Critical Success Index, Informedness, Markedness, F-1 Score, Matthews Correlation Coefficient, and Cohen’s Kappa
  • Graduated from Louisiana Tech University with a BS in Accounting 

Chief Compliance Officer

Chief Compliance Officer

Chief Compliance Officer

image17

Chief Patient Advocate

Chief Compliance Officer

Chief Patient Advocate

image18

Statistician

Chief Compliance Officer

Chief Patient Advocate

image19

Advisers

Health Care Market Adviser

Bio-pharma Industry Adviser

Health Care Market Adviser

image20

Bruce Brandes

Health Care System Adviser

Bio-pharma Industry Adviser

Health Care Market Adviser

image21

Jeff Seraphine

Bio-pharma Industry Adviser

Bio-pharma Industry Adviser

Rare Disease Patient Adviser

image22

Bart Jones

Rare Disease Patient Adviser

Rare Disease Patient Adviser

Rare Disease Patient Adviser

Chip Chambers MD

Chip Chambers MD

Compliance Adviser

Rare Disease Patient Adviser

Compliance Adviser

Cyber Security Adviser

Bio-Pharma Adviser

Rare Disease Patient Adviser

Compliance Adviser

image23

Board

David S. Connor

David S. Connor

David S. Connor

image24

  • CEO & Co-Founder of RDDT
  • 30 years in the pharmaceutical industry
  • 20 years in the rare and ultra rare disease marketplace
  • 7 First to market, first in therapy rare and ultra rare disease product launches
  • 8 Biotech Commercial Start ups
  • Schering-Plough, Rhone Poulenc Rorer, Merck, Guilford, Pharmion, Viropharma, Shire Human Genetics, Aegerion, MTPA 
  • BS, Business Marketing, Florida State University 

Kerry Hart

David S. Connor

David S. Connor

image25

  • COO & Co-Founder RDDT
  • 30 years healthcare corporate leader and entrepreneur
  • CEO of healthcare interim management and operations improvement company
  • CEO of $300MM national case management and physician peer review company
  • National practice leader for Arthur Andersen Business Consulting
  • Led Aetna’s Southeast region managed care operations
  • MA, Organizational Behavior, Western Kentucky University
  • BS, Agribusiness & Journalism, Western Kentucky University

Jeff Seraphine

David S. Connor

Jeff Seraphine

image26

  • 23 years in the hospital and healthcare services sector
  • Chief Development Officer of LifePoint Health
  • President/SVP of 2 Divisions of LifePoint Health (Eastern & Delta Divisions)
  • COO of 1 Division of LifePoint Health (Delta Division)
  • President of Duke LifePoint LLC
  • CEO/COO/President of 3 acute care hospitals (2 LifePoint Health Affiliated)
  • Master’s Degree, Health Care Administration – University of Kentucky
  • BBA, Marketing – University of Kentucky

Mark Smith

Mark Smith

Jeff Seraphine

image27

  • Mark is Owner and Director of Lee Danner and Bass Inc, is a graduate of James Madison University with dual majors in Accounting and Management Information Systems. He is a Certified Public Accountant and was formerly associated with KPMG Peat Marwick. He is the Secretary/Treasurer and Chief Compliance Officer of Lee, Danner & Bass, Inc. and is a member of the CFA Institute. 

Open

Mark Smith

Open

image28

Open

Mark Smith

Open

image29